Product
Innovative Human Platelet Lysate for Advanced Cell Culture
Animal-free human platelet lysate products for research and manufacturing applications in cell culture.
- Distribution Partner
- Biotech and Lifescience
PL BioScience GmbH is a pioneering German biotech company, founded in 2015 as a spin‑off from RWTH Aachen University by Dr. Hatim Hemeda and Christian Wilkes, specializing in the development and production of Human Platelet Lysate (HPL) – a human‑derived, xeno‑free alternative to animal serum like fetal bovine serum (FBS) – PL BioScience has rapidly established itself at the forefront of regenerative medicine and cell therapy.
In May 2025, PL BioScience introduced the world’s first artificial HPL, leveraging lab‑grown platelets sourced through a collaboration with South Korea’s DewCell Biotherapeutics. This marks a breakthrough toward fully scalable, donor‑independent, and ethically produced HPL .
Earlier in April 2025, they launched ELAREM Ultimate‑FD PLUS, the only gamma‑irradiated, fibrinogen‑depleted, GMP‑grade HPL product manufactured in Europe under patent protection
ドイツのバイオテクノロジー企業PL BioScienceは、ヒト血小板溶解物(HPL)と呼ばれるヒト血小板由来の細胞培養培地を提供しています。
Business Type / 業種
Disease Area / 疾患領域
Business Domain / 分野
Modalities / モダリティ
Technologies / 技術
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術
Product
Innovative Human Platelet Lysate for Advanced Cell Culture
Animal-free human platelet lysate products for research and manufacturing applications in cell culture.